3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Gynecologic
2
Plasma cell
1
Lymphoid
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
3147
Triple Negative Breast Neoplasms
515
Ovarian Neoplasms
230
Colorectal Neoplasms
192
Carcinoma, Non-Small-Cell Lung
190
Prostatic Neoplasms
184
Neoplasms
177
Lung Neoplasms
165
Neoplasm Metastasis
164
Melanoma
119
Stomach Neoplasms
114
Pancreatic Neoplasms
113
Endometrial Neoplasms
107
Uterine Cervical Neoplasms
95
Squamous Cell Carcinoma of Head and Neck
88
Head and Neck Neoplasms
82
Colonic Neoplasms
82
Carcinoma, Intraductal, Noninfiltrating
82
Sarcoma
63
Breast Carcinoma In Situ
62
Carcinoma, Renal Cell
61
Urinary Bladder Neoplasms
60
Motor Activity
59
Esophageal Neoplasms
58
Brain Neoplasms
50
Lymphedema
44
Breast Cancer Female
41
Advanced Breast Cancer
40
Liver Neoplasms
39
HER2-positive Breast Cancer
38
Interventions
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
AIDS-related Kaposi sarcoma
×
Breast
×
1 year
×
Clear all
NCT05567601
2025-06-05
Doxil/Caelyx BE Study
Baxter Healthcare Corporation
Phase 1
Completed
36 enrolled